L vs PPCB · P/E 14, rev $18.45B vs P/E 0.0, $3.9M cap
Loews Corp (L) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
PPCB does not have a complete income-statement cache yet.
L currently screens at market cap $22.36B and trailing P/E 13.8. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the L and PPCB stock pages for the full models.
Not investment advice.